Adaptive Biotechnologies Corp Stock Price History
| ADPT Stock | USD 2.40 0.06 2.56% |
Below is the normalized historical share price chart for Adaptive Biotechnologies Corp extending back to June 27, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Adaptive Biotechnologies stands at 2.40, as last reported on the 22nd of April, with the highest price reaching 2.48 and the lowest price hitting 2.28 during the day.
If you're considering investing in Adaptive Stock, it is important to understand the factors that can impact its price. Adaptive Biotechnologies secures Sharpe Ratio (or Efficiency) of -0.16, which signifies that the company had a -0.16% return per unit of standard deviation over the last 3 months. Adaptive Biotechnologies Corp exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Adaptive Biotechnologies' mean deviation of 4.0, and Risk Adjusted Performance of (0.07) to double-check the risk estimate we provide.
At this time, Adaptive Biotechnologies' Total Stockholder Equity is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 811.6 M in 2024, whereas Common Stock Total Equity is likely to drop slightly above 10.3 K in 2024. . At this time, Adaptive Biotechnologies' Price Book Value Ratio is comparatively stable compared to the past year. Price To Book Ratio is likely to gain to 2.41 in 2024, whereas Price Earnings To Growth Ratio is likely to drop (0.06) in 2024. Adaptive Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 27th of June 2019 | 200 Day MA 4.8399 | 50 Day MA 3.3657 | Beta 1.241 |
Adaptive |
Sharpe Ratio = -0.1593
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ADPT |
Estimated Market Risk
| 5.14 actual daily | 45 55% of assets are more volatile |
Expected Return
| -0.82 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.16 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Adaptive Biotechnologies is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Adaptive Biotechnologies by adding Adaptive Biotechnologies to a well-diversified portfolio.
Price Book 1.4161 | Enterprise Value Ebitda (1.00) | Price Sales 2.5648 | Shares Float 96.8 M | Wall Street Target Price 6.4 |
Adaptive Biotechnologies Stock Price History Chart
There are several ways to analyze Adaptive Stock price data. The simplest method is using a basic Adaptive candlestick price chart, which shows Adaptive Biotechnologies price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | February 27, 2024 | 4.27 |
| Lowest Price | April 18, 2024 | 2.34 |
Adaptive Biotechnologies April 22, 2024 Stock Price Synopsis
Various analyses of Adaptive Biotechnologies' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Adaptive Stock. It can be used to describe the percentage change in the price of Adaptive Biotechnologies from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Adaptive Stock.| Adaptive Biotechnologies Price Rate Of Daily Change | 1.03 | |
| Adaptive Biotechnologies Price Action Indicator | 0.05 | |
| Adaptive Biotechnologies Price Daily Balance Of Power | 0.30 |
Adaptive Biotechnologies April 22, 2024 Stock Price Analysis
Adaptive Stock Price History Data
The price series of Adaptive Biotechnologies for the period between Tue, Jan 23, 2024 and Mon, Apr 22, 2024 has a statistical range of 2.03 with a coefficient of variation of 15.43. The prices are distributed with arithmetic mean of 3.5. The median price for the last 90 days is 3.65.| Open | High | Low | Close | Volume | ||
04/22/2024 | 2.31 | 2.48 | 2.28 | 2.40 | ||
| 04/19/2024 | 2.31 | 2.48 | 2.28 | 2.40 | 2,341,515 | |
| 04/18/2024 | 2.45 | 2.46 | 2.33 | 2.34 | 2,780,233 | |
| 04/17/2024 | 2.77 | 2.80 | 2.43 | 2.44 | 3,306,185 | |
| 04/16/2024 | 2.85 | 2.85 | 2.62 | 2.75 | 1,605,771 | |
| 04/15/2024 | 3.01 | 3.11 | 2.88 | 2.91 | 3,152,255 | |
| 04/12/2024 | 2.59 | 3.10 | 2.55 | 3.01 | 6,505,403 | |
| 04/11/2024 | 2.69 | 2.71 | 2.53 | 2.62 | 1,021,794 | |
| 04/10/2024 | 2.83 | 2.83 | 2.64 | 2.67 | 1,268,290 | |
| 04/09/2024 | 2.85 | 3.12 | 2.84 | 2.93 | 1,311,445 | |
| 04/08/2024 | 2.63 | 2.84 | 2.60 | 2.83 | 1,495,669 | |
| 04/05/2024 | 2.72 | 2.72 | 2.56 | 2.58 | 1,324,704 | |
| 04/04/2024 | 2.71 | 2.91 | 2.70 | 2.73 | 1,219,393 | |
| 04/03/2024 | 2.96 | 2.99 | 2.66 | 2.68 | 4,233,032 | |
| 04/02/2024 | 3.03 | 3.05 | 2.90 | 2.98 | 1,054,104 | |
| 04/01/2024 | 3.27 | 3.27 | 3.05 | 3.11 | 1,304,822 | |
| 03/28/2024 | 2.93 | 3.34 | 2.93 | 3.21 | 2,000,090 | |
| 03/27/2024 | 2.95 | 2.95 | 2.75 | 2.89 | 3,386,198 | |
| 03/26/2024 | 3.13 | 3.20 | 2.85 | 2.88 | 1,918,898 | |
| 03/25/2024 | 3.24 | 3.28 | 3.09 | 3.12 | 1,157,058 | |
| 03/22/2024 | 3.31 | 3.32 | 3.15 | 3.24 | 1,607,063 | |
| 03/21/2024 | 3.41 | 3.52 | 3.32 | 3.33 | 816,548 | |
| 03/20/2024 | 3.27 | 3.43 | 3.15 | 3.38 | 1,196,045 | |
| 03/19/2024 | 3.14 | 3.35 | 3.11 | 3.27 | 936,643 | |
| 03/18/2024 | 3.26 | 3.26 | 3.11 | 3.18 | 1,118,908 | |
| 03/15/2024 | 3.23 | 3.34 | 3.21 | 3.24 | 1,751,064 | |
| 03/14/2024 | 3.37 | 3.38 | 3.21 | 3.26 | 1,543,168 | |
| 03/13/2024 | 3.54 | 3.61 | 3.36 | 3.41 | 1,321,497 | |
| 03/12/2024 | 3.77 | 3.79 | 3.58 | 3.59 | 1,301,205 | |
| 03/11/2024 | 3.63 | 3.95 | 3.59 | 3.78 | 1,624,211 | |
| 03/08/2024 | 3.53 | 3.75 | 3.48 | 3.65 | 1,626,671 | |
| 03/07/2024 | 3.64 | 3.76 | 3.44 | 3.45 | 1,381,181 | |
| 03/06/2024 | 3.85 | 3.88 | 3.53 | 3.61 | 1,694,562 | |
| 03/05/2024 | 3.40 | 3.80 | 3.40 | 3.78 | 3,411,753 | |
| 03/04/2024 | 4.04 | 4.08 | 3.76 | 3.99 | 1,274,771 | |
| 03/01/2024 | 4.11 | 4.25 | 3.99 | 4.03 | 1,152,332 | |
| 02/29/2024 | 4.29 | 4.33 | 4.11 | 4.11 | 1,035,665 | |
| 02/28/2024 | 4.17 | 4.35 | 4.09 | 4.15 | 1,258,795 | |
| 02/27/2024 | 4.24 | 4.34 | 4.10 | 4.27 | 1,000,998 | |
| 02/26/2024 | 4.02 | 4.18 | 3.96 | 4.16 | 879,519 | |
| 02/23/2024 | 3.87 | 4.08 | 3.79 | 4.04 | 1,123,480 | |
| 02/22/2024 | 3.85 | 3.95 | 3.73 | 3.88 | 1,631,215 | |
| 02/21/2024 | 3.83 | 3.89 | 3.75 | 3.82 | 873,328 | |
| 02/20/2024 | 3.86 | 3.97 | 3.76 | 3.85 | 1,235,567 | |
| 02/16/2024 | 3.91 | 4.05 | 3.81 | 3.85 | 1,930,187 | |
| 02/15/2024 | 3.60 | 4.24 | 3.60 | 3.96 | 5,278,947 | |
| 02/14/2024 | 3.66 | 4.01 | 3.65 | 3.94 | 1,718,146 | |
| 02/13/2024 | 3.66 | 3.78 | 3.54 | 3.62 | 1,467,508 | |
| 02/12/2024 | 3.73 | 3.99 | 3.69 | 3.92 | 1,453,999 | |
| 02/09/2024 | 3.75 | 3.80 | 3.65 | 3.78 | 879,825 | |
| 02/08/2024 | 3.58 | 3.71 | 3.50 | 3.67 | 1,245,932 | |
| 02/07/2024 | 3.80 | 3.80 | 3.55 | 3.57 | 1,027,993 | |
| 02/06/2024 | 3.46 | 3.77 | 3.41 | 3.77 | 1,179,663 | |
| 02/05/2024 | 3.56 | 3.56 | 3.45 | 3.46 | 936,065 | |
| 02/02/2024 | 3.65 | 3.72 | 3.52 | 3.65 | 962,491 | |
| 02/01/2024 | 3.70 | 3.79 | 3.64 | 3.74 | 1,232,586 | |
| 01/31/2024 | 3.95 | 4.00 | 3.67 | 3.67 | 1,374,400 | |
| 01/30/2024 | 4.09 | 4.11 | 3.94 | 3.95 | 811,557 | |
| 01/29/2024 | 3.95 | 4.16 | 3.85 | 4.13 | 993,759 | |
| 01/26/2024 | 4.02 | 4.24 | 3.94 | 3.95 | 1,268,917 | |
| 01/25/2024 | 4.19 | 4.27 | 3.92 | 4.00 | 1,699,623 |
About Adaptive Biotechnologies Stock history
Adaptive Biotechnologies investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Adaptive is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Adaptive Biotechnologies will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Adaptive Biotechnologies stock prices may prove useful in developing a viable investing in Adaptive Biotechnologies
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 144.4 M | 131.8 M | |
| Net Loss | -180.2 M | -189.2 M |
Adaptive Biotechnologies Quarterly Net Working Capital |
|
Adaptive Biotechnologies Stock Technical Analysis
Adaptive Biotechnologies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run ETFs Now
ETFsFind actively traded Exchange Traded Funds (ETF) from around the world |
| All Next | Launch Module |
Adaptive Biotechnologies Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Adaptive Biotechnologies' price direction in advance. Along with the technical and fundamental analysis of Adaptive Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Adaptive to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.81) | |||
| Total Risk Alpha | (1.30) | |||
| Treynor Ratio | (0.36) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adaptive Biotechnologies Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Complementary Tools for Adaptive Stock analysis
When running Adaptive Biotechnologies' price analysis, check to measure Adaptive Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adaptive Biotechnologies is operating at the current time. Most of Adaptive Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Adaptive Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adaptive Biotechnologies' price. Additionally, you may evaluate how the addition of Adaptive Biotechnologies to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
Is Adaptive Biotechnologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adaptive Biotechnologies. If investors know Adaptive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adaptive Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.56) | Revenue Per Share 1.179 | Quarterly Revenue Growth (0.17) | Return On Assets (0.17) | Return On Equity (0.58) |
The market value of Adaptive Biotechnologies is measured differently than its book value, which is the value of Adaptive that is recorded on the company's balance sheet. Investors also form their own opinion of Adaptive Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adaptive Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adaptive Biotechnologies' market value can be influenced by many factors that don't directly affect Adaptive Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adaptive Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adaptive Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adaptive Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.